Gilead Sciences Sinks To Quarterly Loss On Remdesivir And M&A Costs
31 Juli 2020 - 6:49AM
Alliance News
Gilead Sciences
Inc on Thursday reported a loss in the second quarter as
significantly higher costs added to falling ...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Gilead Sciences (TG:GIS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Gilead Sciences (TG:GIS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024